ConductScience.org, home

Gene · 55540

Papers2,488

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

181 to 200 of 2,488

Download this page as JSON
TitleJournalYearPMIDFound bySource
SMC5/6 Promotes Replication Fork Stability via Negative Regulation of the COP9 Signalosome.Int J Mol Sci202438256025PubTator, text miningPubMed
Umbilical Cord Mesenchymal Stromal/Stem Cells and Their Interplay with Th-17 Cell Response Pathway.Cells202438247860PubTator, text miningPubMed
Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic.EBioMedicine202438244292PubTator, text miningPubMed
TRIM for Tissue Specificity.ACS Med Chem Lett202438229746PubTator, text miningPubMed
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines.Nat Commun202438228616PubTator, text miningPubMed
The Cross-Regulation Between Set1, Clr4, and Lsd1/2 in Schizosaccharomyces pombe.PLoS Genet202438181050PubTator, text miningPubMed
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα.Chem Sci202438179525PubTator, text miningPubMed
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.Nat Commun202438177131PubTator, text miningPubMed
Live-cell imaging of endogenous CSB-mScarletI as a sensitive marker for DNA-damage-induced transcription stress.Cell Rep Methods202438176411PubTator, text miningPubMed
Induced protein degradation for therapeutics: past, present, and future.J Clin Invest202438165043PubTator, text miningPubMed
DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.J Exp Clin Cancer Res202438163876PubTator, text miningPubMed
Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.Chembiochem202438116854PubTator, text miningPubMed
Rationally designed approaches to augment CAR-T therapy for solid tumor treatment.Bioact Mater202438059121PubTator, text miningPubMed
Circular RNA in cervical cancer: Fundamental mechanism and clinical potential.Noncoding RNA Res202438035041PubTator, text miningPubMed
ELM-the Eukaryotic Linear Motif resource-2024 update.Nucleic Acids Res202437962385PubTator, text miningPubMed
DCAF14 regulates CDT2 to promote SET8-dependent replication fork protection.Life Sci Alliance202437940188PubTator, text miningPubMed
Biomarkers predictive of a response to extended endocrine therapy in breast cancer: a systematic review and meta-analysis.Breast Cancer Res Treat202437878151PubTator, text miningPubMed
Design principles for cyclin K molecular glue degraders.Nat Chem Biol202437679459PubTator, text miningPubMed
IL17RB expression is associated with malignant cancer behaviors and poor prognosis in oral cancer.Oral Dis202437448179PubTator, text miningPubMed
Recent advances in targeted protein degraders as potential therapeutic agents.Mol Divers202436790583PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/55540/papers?page=10